Governments are currently permitted to issue patent compulsory licenses under World Trade Organization Rules, which allow countries to manufacture cheaper versions of patented drugs for non-commercial use or in cases of health care emergencies. In a forthcoming paper entitled "Confronting Myths and Myopia on the Road from Doha" (soon to be published in the Georgia Law Review), one commentator reviews the current compulsory licensing system and discusses three myths that have obscured workable remuneration rules. The paper then argues for a three-tiered arrangement, in which remuneration is based on the economic status of the country issuing the compulsory license.

For more information, please see: